Steve Duffy, Author at Hematology Advisor

Steve Duffy

All articles by Steve Duffy

FDA Approves Epoetin Alfa Biosimilar Retacrit

The approval of Retacrit was based on a review of evidence that included human pharmacokinetic/pharmacodynamic data and clinical immunogenicity data which demonstrated a high degree of similarity between Retacrit and its reference product.

Next post in Anemia